pindolol has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farsang, C | 1 |
| Kapocsi, J | 1 |
| Kiss, I | 1 |
| Török, E | 1 |
| Kerkovits, G | 1 |
| Holló, J | 1 |
| Jávor, T | 1 |
| Carleo, R | 1 |
| Dell'Aversano, R | 1 |
| Gatti, A | 1 |
| Monda, M | 1 |
| Vigilante, M | 1 |
| Antonucci, G | 1 |
1 trial available for pindolol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Dru | 1994 |
1 other study available for pindolol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Effect of mepindolol on the regulation of glucose metabolism].
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pindolo | 1987 |